跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,746 条关于
“JNJ-5120/PIPE-307”
全部
6,746
临床试验
3,670
药物
2,346
机构
15
资讯
715
上个月
Contineum's JNJ-5120/PIPE-307 Misses Primary Endpoint in Phase 2 MOONLIGHT-1 Depression Trial
3天前
J&J's M1 Antagonist PIPE-307 Misses Primary Endpoint in Phase 2 MDD Trial, Second Setback for the Molecule
去年
Contineum Therapeutics On Track for Key Clinical Milestones with PIPE-791 and PIPE-307 Programs
10个月前
Contineum Therapeutics' PIPE-307 Fails Phase 2 Multiple Sclerosis Trial
去年
Contineum Therapeutics Completes Enrollment in Phase 2 Trial of PIPE-307 for Relapsing-Remitting Multiple Sclerosis
6个月前
Contineum Therapeutics Advances PIPE-791 Phase 2 Trial for Idiopathic Pulmonary Fibrosis with Differentiated LPA1 Receptor Targeting
去年
Contineum Therapeutics Initiates Dosing in Phase 1b Trial of PIPE-791 for Multiple Sclerosis
去年
Contineum Therapeutics Reports Positive Phase 1b PET Trial Results for PIPE-791 in Multiple Sclerosis and Pulmonary Fibrosis
2个月前
Talawar Therapeutics to Go Public via SPAC Merger, Secures $225M PIPE to Advance Bispecific Antibody for Atopic Dermatitis
去年
JNJ-2113 Shows Promising Phase 3 Results for Plaque Psoriasis
第 1 页,共 72 页
上一页
下一页